Related Experiment Video
Updated: Nov 3, 2025

05:23
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
1.4K
Breast Cancer Cell Re-Dissemination from Lung Metastases-A Mechanism for Enhancing Metastatic Burden
Lucia Borriello1,2, John Condeelis1,2,3,4, David Entenberg1,2,4
1Department of Anatomy and Structural Biology, Montefiore Medical Center, Einstein College of Medicine, Bronx, NY 10461, USA.
Journal of Clinical Medicine
|June 2, 2021
Summary
Cancer cells can spread from lung metastases, not just primary tumors. This re-dissemination after primary tumor removal may drive metastatic disease progression and patient mortality.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Metastatic disease is the leading cause of cancer-related mortality.
- The multi-step process of metastasis includes cancer cell intravasation, dissemination, and outgrowth.
- Mechanisms driving overwhelming metastatic burden remain incompletely understood.
Purpose of the Study:
- To investigate the origin of cancer cell dissemination in metastatic disease.
- To determine if metastatic dissemination occurs from sites beyond primary tumors and lymph nodes.
- To elucidate potential mechanisms contributing to extensive metastatic burden.
Main Methods:
- The study analyzed the dissemination patterns of breast cancer cells.
- Investigated cancer cell spread originating from established lung metastases.
- Examined the implications of dissemination from secondary tumor sites.
Main Results:
- Breast cancer cells were found to disseminate from lung metastases, not solely from primary tumors or lymph nodes.
- This indicates that metastatic dissemination can continue even after primary tumor removal.
- Cancer cell re-dissemination from metastatic foci is identified as a potential driver of disease progression.
Conclusions:
- Metastatic dissemination is a dynamic process that can originate from established metastases.
- Re-dissemination from metastatic sites may significantly contribute to overall metastatic burden.
- Targeting cancer cell re-dissemination presents a potential therapeutic strategy to improve patient survival in metastatic cancer.
Related Concept Videos
Metastasis
5.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Tumor Progression
6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K

